EXEL vs ICE · P/E 17, rev $1.24B vs P/E 37, rev $7.28B
Exelixis Inc (EXEL) versus Intercontinental Exchange Inc (ICE) — a side-by-side from cached financials, not a winner call.
Exelixis Inc (EXEL) is a biotechnology company listed on US.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Latest reported EXEL revenue for 2026-07-03 was $1.24B. Net income was $422.5M. EXEL currently screens at market cap $12.69B and trailing P/E 16.7.
Latest reported ICE revenue for 2026-06-30 was $7.28B. Net income was $2.37B. Revenue was up 98.5% from 2026-03-31 to 2026-06-30. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
EXEL currently screens at market cap $12.69B and trailing P/E 16.7. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Not investment advice. Open the EXEL and ICE stock pages for the full models.
Not investment advice.